G. G. Torgomyan

G. G. Torgomyan

Auto-generated profile, based on publicly available information

G. G. Torgomyan

Nizhny Novgorod Regional Clinical Oncological Dispensary

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 September 2019 in Methods and Applications in Fluorescence
Verified
Journal Article
Closed access
SRSvetlana Rodimova
Svetlana Rodimova
AMAleksandra V Meleshina
Aleksandra V Meleshina
EKEkaterina Kalabusheva
Ekaterina Kalabusheva
EDErdem B Dashinimaev
Erdem B Dashinimaev
DRDmitry G Reunov
Dmitry G Reunov
EZElena V Zagaynova
Elena V Zagaynova
Induced pluripotent stem cells (iPSC) are a promising tool for personalized cell therapy, in particular, in the field of dermatology. Metabolic plasticity of iPSC are not completely understood due to the fact that iPSC have a mixed mitochondrial phenotype, which still resembles that of somatic cells. In this study we investigated the metabolic changes in iPSC undergoing differentiation in two directions, dermal and epidermal, using two-photon fluorescence microscopy combined with FLIM. Directed differentiation of iPSC into dermal fibroblasts and keratinocyte progenitor cells was induced. Cellular metabolism was examined on the basis of the fluorescence of the metabolic cofactors NAD(P)H and FAD. The optical redox ratio (FAD/NAD(P)H) and the fluorescence lifetimes of NAD(P)H and FAD were traced using two-photon fluorescence microscopy combined with FLIM. Evaluation of the intracellular pH was carried out with the fluorescent pH sensor SypHer-2 and fluorescence microscopy. In this study, evaluation of the metabolic status of iPSC during dermal and epidermal differentiation was accomplished for the first time with the use of optical metabolic imaging. Based on the data on the FAD/NAD(P)H redox ratio and on the fluorescence lifetimes of protein-bound form of NAD(P)H and closed form of FAD, we registered a metabolic shift toward a more oxidative status in the process of iPSC differentiation into dermal fibroblasts and keratinocyte progenitor cells. Biosynthetic processes occurring in dermal fibroblasts associated with the synthesis of fibronectin and versican, that stimulate increased energy metabolism and lower the intracellular pH. No intracellular pH shift is observed in the culture of keratinocyte progenitor cells, which reflects the incomplete process of differentiation in this type of cells. Presented results provide the basis for further understanding the metabolic features of iPSC during differentiation process, which is essential for developing new treatment strategies in cell therapy and tissue engineering.

11 August 2025 in Pirogov Russian Journal of Surgery
Verified
Journal Article
Closed access
ARA.B. Ryabov
A.B. Ryabov
OPO.V. Pikin
O.V. Pikin
VKV.M. Khomyakov
V.M. Khomyakov
IKI.V. Kolobaev
I.V. Kolobaev
ETE.A. Toneev
E.A. Toneev
AMA.A. Martynov
A.A. Martynov
Objective. To analyze short-term outcomes of the McKeown esophagectomy in 4 cancer centers of the Russian Federation. Material and methods. The study included 175 patients who underwent open, hybrid or minimally invasive McKeown esophagectomy between 2016 and 2023 in 4 cancer centers of the Russian Federation. Traditional open esophagectomy was performed in 69 (39.4%) patients, hybrid — in 78 (44.6%), minimally invasive — in 28 (16%) patients. Results. Median time of minimally invasive surgery was 395 min [358.25; 436.25], hybrid procedure — 357.5 min [300.00; 403.75], open esophagectomy — 315 min [265.00; 390.00] (p<0.001). Mean blood loss was 175, 150 and 300 ml, respectively (p<0.001). Conversion rate for hybrid interventions was 2.5%, for minimally invasive esophagectomy — 3.5%. Mean number of resected lymph nodes was higher in minimally invasive groups (open — 19.7±7.5; hybrid — 21.3±13.1; minimally invasive esophagectomy — 21.7±12.4 p=0.007). Major postoperative complications (TMM classification) comprised 8.7% in open surgeries and 20.7% in hybrid and minimally invasive procedures (p=0.031). Pulmonary complications were more common after open esophagectomy (17.4%) compared to hybrid and minimally invasive procedures (7.5%) (p=0.041). Incidence of type 2 and 3 anastomotic leaks was 6.4% in hybrid surgery, 8.6% in open surgery and 10.7%in minimally invasive procedures (p=0.387). Postoperative in-hospital mortality was 8.6% for open esophagectomy, 5.1% for hybrid esophagectomy and 3.5% for minimally invasive procedures (p=0.049). Hospital-stay was 19 days for open esophagectomy and 14 days for hybrid and minimally invasive procedures (p=0.219). Conclusion. Minimally invasive esophagectomy for thoracic esophageal cancer significantly reduces the incidence of postoperative pulmonary complications and intraoperative blood loss, as well as increases the number of removed lymph nodes.

11 April 2020 in Malignant tumours
Verified
Journal Article
Open access
PDF file
NKN. M. Kiselev
N. M. Kiselev
NBN. V. Bobrov
N. V. Bobrov
DKD. M. Kuchin
D. M. Kuchin
GTG. G. Torgomyan
G. G. Torgomyan
LSL. V. Shkalova
L. V. Shkalova
VZV. E. Zagainov
V. E. Zagainov
Primary malignant melanoma of the esophagus is a rare disease with an aggressive course and poor prognosis. This article presents a review of the world literature on this specific disease, including incidence statistics, modern principles of diagnosis and treatment, as well as a clinical case of a patient with resectable esophageal melanoma.

14 September 2026 in Pirogov Russian Journal of Surgery
Verified
Journal Article
Closed access
ARA.B. Ryabov
A.B. Ryabov
NAN.M. Abdulkhakimov
N.M. Abdulkhakimov
VAV.G. Agadzhanov
V.G. Agadzhanov
MAM.V. Agasiev
M.V. Agasiev
AAA.E. Anisimov
A.E. Anisimov
DSD.D. Sekhniaidze
D.D. Sekhniaidze
Objective. To evaluate 90-day morbidity and mortality rates after elective radical surgery for esophageal and esophagogastric junction cancer within the prospective multiple-center study ESOSTAT. Material and methods. The study included 230 patients from 18 oncology hospitals in the Russian Federation and the Republic of Belarus who underwent elective radical esophagectomy for primary esophageal cancer or esophagogastric junction cancer (Siewert I–II) between March 18 and September 18, 2024. Complications were uniformly recorded using the ESODATA system with severity graded according to the Clavien-Dindo classification. Univariate and multivariate logistic regression analyses were performed to identify risk factors of postoperative complications and mortality. Results. The 90-day mortality rate was 8.7%, in-hospital mortality — 4.8%. The overall complication rate was 41.3%, including surgical complications in 26.5% of patients and redo surgeries in 17.4% of cases. The most common complications were pulmonary (22.1%) and anastomotic leakage (11.3%). The mortality rate associated with anastomotic leakage was 19.2%. Multivariate analysis identified female sex (OR=0.732; 95% CI 0.548–0.978; p=0.035), ECOG status 2 (OR=10.142; 95% CI 1.575–65.366; p=0.015), surgery time (OR=1.003; 95% CI 1.001–1.005; p=0.006), and intraoperative blood loss (OR=1.001; 95% CI 1.000–1.002; p=0.027) as independent predictors of complications. Factors independently associated with 90-day mortality were Charlson comorbidity index >4 (OR=1.260; 95% CI 1.062–1.495; p=0.008), complicated course of esophageal cancer (OR=1.560; 95% CI 0.637–2.305; p=0.025), concomitant pulmonary diseases (OR=3.328; 95% CI 1.083–10.227; p=0.036), and any postoperative complication (OR=36.554; 95% CI 15.800–84.521; p<0.001). Conclusion. The ESOSTAT study is the first in Russia and Belarus to evaluate 90-day morbidity and mortality rates after esophagectomy. Our findings are comparable with international registries, support 90-day follow-up period and identify key prognostic factors. Risk factor analysis will allow patient stratification according to the likelihood of adverse outcomes, facilitate more rigorous patient selection, and ultimately improve safety of surgical treatment.

20 September 2026 in Almanac of Clinical Medicine
Verified
Journal Article
Open access
PDF file
ETEvgeny A. Toneev
Evgeny A. Toneev
ТАТонеев Евгений Александрович
Тонеев Евгений Александрович
NKNikolai M. Kiselev
Nikolai M. Kiselev
КМКиселев Николай Михайлович
Киселев Николай Михайлович
MRMaksim S. Rudenko
Maksim S. Rudenko
ЗРЗиганшина Сюмбель Радиковна
Зиганшина Сюмбель Радиковна
Background: Esophagectomy remains a high-risk surgical procedure associated with substantial postoperative complications and mortality. Preoperative risk stratification requires simple, reproducible tools to account for the cumulative comorbidity burden. Aim: To evaluate the association of comorbidity burden, assessed via the Charlson comorbidity index, with postoperative complications and long-term outcomes after esophagectomy in patients with esophageal cancer. Methods: This multicenter retrospective cohort study included a consecutive sample of 411 patients who underwent an Ivor Lewis or McKeown esophagectomy at four oncological centers in Russia between January 1, 2014 and May 1, 2026. Patients were stratified into two groups: Charlson 5 (n = 277) and Charlson ≥ 5 (n = 134). The primary endpoint was postoperative complications, defined as the occurrence of at least one of the following: anastomotic leakage, reoperation, in-hospital mortality, or 90-day mortality. Overall and progression-free survival were analyzed in 392 patients with confirmed follow-up data. Results: Postoperative complications occurred in 104/411 (25.3%) patients and were significantly more frequent in the Charlson ≥ 5 group compared to the Charlson 5 group: 35.8% vs 20.2%; odds ratio (OR) 2.20 (95% confidence interval (CI) 1.39–3.49; p 0.001). After adjusting for clinical-oncological and surgical factors, Charlson ≥ 5 maintained an independent association with the outcome: adjusted OR 2.03 (95% CI 1.22–3.39; p = 0.007). In the individual comorbidities model, coronary artery disease and chronic obstructive pulmonary disease were identified as significant predictors. Patients with Charlson ≥ 5 exhibited higher rates of anastomotic leakage (29/134 (21.6%) vs 33/277 (11.9%), p = 0.01), in-hospital mortality (22/134 (16.4%) vs 17/277 (6.1%), p 0.001) and 90-day mortality (29/134 (21.6%) vs 23/277 (8.3%), p 0.001). Median overall survival was 22 vs 40 months (p = 0.029), and median progression-free survival was 14 vs 30 months (p = 0.007). In the multivariable model, Charlson ≥ 5 was associated with worse progression-free survival: hazard ratio 1.38 (95% CI 1.01–1.89; p = 0.042). Conclusion: A Charlson comorbidity index score ≥ 5 was independently associated with postoperative complications and worse progression-free survival after esophagectomy. It can serve as an accessible tool for preoperative risk stratification.